[Cerivastatin and the PRINCESS study: reflexions after 1 year].
Manfredi
Carlo
C
Dell'Ordine dei Medici della Provincia di Massa Carrara e della Sottocommissione per la Sperimentazione del Comitato Etico Locale dell'ASL 1 di Massa e Carrara.
Macrì
Rocco
R
Bartoli
Marco
M
D002986:Clinical Trials as Topic; D004335:Drug and Narcotic Control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D017202:Myocardial Ischemia / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D012107:Research Design
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; C086276:cerivastatin